Evolution Wealth Advisors, LLC Fibrogen Inc Transaction History

Evolution Wealth Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 09, 2021	SELL	$10.18 - $26.64 $2,494 - $6,526	-245 Closed	0 $0
Q1 2020 Apr 22, 2020	BUY	$23.3 - $45.96 $489 - $965	21 Added 9.38%	245 $9,000
Q4 2019 Feb 03, 2020	BUY	$34.58 - $48.06 $7,019 - $9,756	203 Added 966.67%	224 $10,000
Q3 2019 Nov 12, 2019	SELL	$36.98 - $48.45 $7,506 - $9,835	-203 Reduced 90.63%	21 $1,000
Q2 2019 Jul 12, 2019	BUY	$35.13 - $55.53 $7,869 - $12,438	224 New	224 $10,000

47.1M

387K

672K

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $37.5M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

Get notified when there are updates to the investment portfolio of Evolution Wealth Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Evolution Wealth Advisors, LLC with notifications on news.